Deborah E. Citrin
Senior Investigator
Center for Cancer Research
National Cancer Institute
United States of America
Biography
Dr. Citrin is a clinician and translational researcher in the Radiation Oncology Branch at NCI. She is a graduate of the Duke University School of Medicine and completed her residency training at NCI and the National Capital Consortium. She joined the NIH in 2001. Her research interests include the pre-clinical and clinical testing of radiation modifiers and the mechanisms of normal tissue injury from radiation. Dr. Citrin is involved in the clinical care of patients with genitourinary cancers (prostate and bladder), gastrointestinal cancers, and melanoma. Dr. Citrin is board certified by the American Board of Radiology.
Research Interest
prostate cancer, bladder cancer, gastrointestinal (GI) cancer, radiation normal tissue injury, radiation fibrosis, radiation modifiers
Publications
-
Chung EJ, McKay-Corkum G, Chung S, White A, Scroggins BT, Mitchell JB, Mulligan-Kehoe MJ, Citrin D. Truncated plasminogen activator inhibitor-1 protein protects from pulmonary fibrosis mediated by irradiation in a murine model. International Journal of Radiation Oncology* Biology* Physics. 2016 Apr 1;94(5):1163-72.
-
Goff SL, Dudley ME, Citrin DE, Somerville RP, Wunderlich JR, Danforth DN, Zlott DA, Yang JC, Sherry RM, Kammula US, Klebanoff CA. Randomized, prospective evaluation comparing intensity of lymphodepletion before adoptive transfer of tumor-infiltrating lymphocytes for patients with metastatic melanoma. Journal of Clinical Oncology. 2016 May 23;34(20):2389-97.
-
Citrin DE. Short-Term Screening Assays for the Identification of Therapeutics for Cancer. Cancer research. 2016 Jun 15;76(12):3443-5.
